SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir shares experienced extreme volatility as a sharp intraday selloff reversed following an unexpected social media post from President Trump, who praised the company's defense and war-fighting capabilities. This event sparked intense debate among the community, with many traders framing the price action as a clash between presidential market influence and the ongoing bearish arguments posed by figures like Michael Burry.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending on the back of a major expanded AI infrastructure agreement with Meta, which has fueled intense community debate over long-term revenue visibility versus ongoing concerns regarding debt, dilution, and high capital expenditure requirements. Traders are closely monitoring the stock's price action as they weigh the impact of these massive contract commitments against the company's aggressive financing strategy.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing significant downward pressure as investors rotate out of the software sector due to AI-driven disruption concerns and intense volatility ahead of the company's upcoming earnings release. While some in the community argue the stock is fundamentally oversold and essential for enterprise AI infrastructure, bearish sentiment remains elevated as traders monitor critical support levels and executive leadership changes.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing a sharp selloff driven by aggressive analyst downgrades and growing investor anxiety that AI disruption from competitors like Anthropic could erode the company's enterprise software moat. While some market participants are taking advantage of the steep price decline to accumulate shares, others remain skeptical, citing technical weakness and the broader rotation of capital away from subscription-based SaaS models toward AI infrastructure.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. (ALOY) is attracting significant community attention due to its strategic positioning in the rare earth metals supply chain, buoyed by major contract awards and a new board featuring high-profile defense experts. While bullish investors emphasize its role in reducing dependency on foreign suppliers ahead of upcoming defense procurement mandates, some market participants remain cautious regarding the stock's recent volatility and the potential for long-term dilution as the company expands its production capabilities.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing intense volatility driven by shifting sentiment around geopolitical headlines and trader speculation on AI infrastructure growth. The community remains deeply divided, with bulls pointing to the company's long-term potential and product roadmaps while bears cite concerns over market overvaluation and potential negative impacts from macro events.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

Investors are closely monitoring the iShares Expanded Tech-Software Sector ETF as broader software indices show signs of a recovery. Market participants are actively debating the potential for sustained momentum in key enterprise software holdings as the sector attempts to rebound from recent volatility.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is facing intense downward pressure as investors rotate out of the software sector, fueled by fears that AI automation and agents could disrupt traditional SaaS business models. Despite management's massive share buyback program and integration of advanced AI tools, the market is actively debating whether current valuation levels represent a generational buying opportunity or a structural decline in the face of rapid technological displacement.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending following news that Netflix officially abandoned its pursuit of the company, clearing the path for Paramount Skydance to acquire WBD in a deal valued at approximately $111 billion. Investors are closely monitoring the stock as it aligns toward the acquisition price, with community discussions heavily focused on the implications of the high debt load for the combined entity and the potential for a swift regulatory approval process.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing volatile price action driven by speculative momentum and a clash between retail bulls and short sellers following the company's recent earnings report and the filing of a 60 million dollar at-the-market equity distribution program. While some traders are betting on a continued squeeze fueled by sentiment around photonics and AI infrastructure, others are aggressively shorting the stock, citing a disconnect between the company's high market valuation and its current revenue and profit margins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen research firms that are covering the company, Marketbeat...

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK...

Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference. The corporate presentation...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Up 6.9% - What's Next?

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.9% - Should You Buy...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Up 9% - Still a Buy?

Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Up 9% - Time to Buy...

HC Wainwright Reaffirms Buy Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX)

HC Wainwright reissued a "buy" rating and issued a $34.00 price target on shares of Amylyx Pharmaceuticals in a research note on Wednesday...

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today announced that the last participant has been randomized and dosed in the pivotal Phase 3 LUCIDITY clinical trial of...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price Expected to Rise, Guggenheim Analyst Says

Guggenheim upped their price target on shares of Amylyx Pharmaceuticals from $25.00 to $30.00 and gave the company a "buy" rating in a research note on Thursday...

Maven Securities LTD Makes New $951,000 Investment in Amylyx Pharmaceuticals, Inc. $AMLX

Maven Securities LTD purchased a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the third quarter, according to the company in its most recent disclosure with the...

First Light Asset Management LLC Purchases Shares of 3,355,882 Amylyx Pharmaceuticals, Inc. $AMLX

First Light Asset Management LLC purchased a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with...

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.33	--	--	N/A
Q4 '25	-$0.35	-$0.30	13.96%	BEAT
Q3 '25	-$0.44	-$0.37	15.10%	BEAT
Q2 '25	-$0.44	-$0.46	-3.50%	MISSED
Q1 '25	-$0.47	-$0.42	11.58%	BEAT

AMLX
Amylyx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AMLX News

AMLXAmylyx Pharmaceuticals Inc